Event

Pulmonologists play a key role in the prevention, early diagnosis, prompt tissue diagnosis, staging, and treatment of patients with lung cancer; early intervention improves survival. As the precision medicine landscape continues to evolve, the relevance of clinical genetics is intersecting with the advancing science of tumor genomic profiling. This increases the responsibility of clinician pulmonologists in understanding and interpreting genomic tests on tumor biopsy they obtain. However, there is a significant knowledge gap among pulmonologists in understanding their role in utilizing genomics as a clinical tool. Our goal is to delineate the role of Pulmonologist in decoding Genomic Clinical Tool using Five Different Case Scenarios with specific molecular diagnosis leading to best selection of treatment options for each of those cases. Five Different Case Scenarios will be presented in the Form of Genomic Specific Tumor Board leading to best selection of treatment options for each of those cases with specific molecular diagnosis EGFR, KRAS, ALK, MET and TSC1 utilizing clinical context that can be used by pulmonary clinician in their daily practice.